Featured Resources

Most Recent

Scarsin supports Uxbridge-led Ghana Surgical Program
Scarsin supports Uxbridge-led Ghana Surgical Program
Scarsin supports fourth surgical mission to Carpenter, Northern Ghana. Medical Mission will embark on November 11th for two weeks led by Uxbridge-based Dr. Jennifer Wilson. Scarsin’s donation will be used to provide...
Scarsin included as a PROFIT 500 company for 2016
Scarsin included as a PROFIT 500 company for 2016
PROFIT magazine unveils the 28th annual list of Canada’s Fastest-Growing Companies and Scarsin makes the list again. “We are very excited to be named on this prestigious list along with so many other Canadian companies...
Scarsin makes significant donation to Precious Minds
Scarsin makes significant donation to Precious Minds
Scarsin makes a significant commitment to Precious Minds, a charitable organization dedicated to supporting children, adolescents and adults with developmental disabilities in North Durham Region.
IDC Insight Paper
IDC Insight Paper
A modern enterprise forecasting software solution wouldn't require users to give up spreadsheets — the most familiar software for forecasters. Instead these solutions, would use a spreadsheet interface as a window into an enterprise-class platform...
Download IDC Insight Paper
Scarsin achieves SOC 2 Type 2 Attestation Report
Scarsin achieves SOC 2 Type 2 Attestation Report
Toronto, December 3rd 2015 – Scarsin Corporation today announced that the company has successfully completed Service Organization Control 2 (SOC 2) Type 2 Attestation
i2e for Pharma PowerPoint Automation
i2e for Pharma PowerPoint Automation
The customer is a leading pharmaceutical company with global operations and a wide portfolio of products. The project engagement involved supporting a multi-billion dollar regional business unit with 28 reporting countries and 9 existing brands.
/i2e-pharma-ppt-automation.htm
i2e for Pharma - Integrated BI
The customer is a Global pharmaceutical company with responsibility for reporting and forecasting across a business unit (which includes 7 Therapeutic Areas) for 21 countries. This included Canada, Australia and selected European markets...
/i2e-pharma-bi-platform.htm